BioNexus Gene Lab
(NASDAQ) BGLC
BioNexus Gene Lab Financials at a Glance
Market Cap
$3.97M
Revenue (TTM)
$9.47M
Net Income (TTM)
$2.30M
EPS (TTM)
$-1.28
P/E Ratio
-1.73
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Price
$2.14
Volume
1,659
Open
$2.27
Price
$2.14
Volume
1,659
Open
$2.27
Previous Close
$2.21
Daily Range
$2.19 - $2.27
52-Week Range
$1.92 - $15.60
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Price
$2.14
Volume
1,659
Open
$2.27
Previous Close
$2.21
Daily Range
$2.19 - $2.27
52-Week Range
$1.92 - $15.60
BGLC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioNexus Gene Lab
Industry
Trading Companies and Distributors
Sector
IndustrialsEmployees
30
CEO
Su Leng Tan Lee
Website
www.bionexusgenelab.comHeadquarters
Kuala Lumpur, 59200, MY
BGLC Financials
Key Financial Metrics (TTM)
Gross Margin
15%
Operating Margin
-25%
Net Income Margin
-24%
Return on Equity
-28%
Return on Capital
-34%
Return on Assets
-30%
Earnings Yield
-57.80%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.97M
Shares Outstanding
1.80M
Volume
1.66K
Short Interest
0.00%
Avg. Volume
20.83K
Financials (TTM)
Gross Profit
$1.29M
Operating Income
$1.57M
EBITDA
$1.42M
Operating Cash Flow
$2.23M
Capital Expenditure
$226.99K
Free Cash Flow
$2.46M
Cash & ST Invst.
$4.38M
Total Debt
$210.56K
BioNexus Gene Lab Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.54M
-3.3%
Gross Profit
$377.69K
+15.7%
Gross Margin
14.85%
N/A
Market Cap
$3.97M
N/A
Market Cap/Employee
$132.24K
N/A
Employees
30
N/A
Net Income
$708.99K
+47.3%
EBITDA
$665.64K
+48.3%
Quarterly Fundamentals
Net Cash
$2.71M
-30.7%
Accounts Receivable
$1.63M
+12.3%
Inventory
$1.01M
-27.5%
Long Term Debt
$126.94K
-28.8%
Short Term Debt
$56.80K
+17.8%
Return on Assets
-30.14%
N/A
Return on Invested Capital
-33.82%
N/A
Free Cash Flow
$1.24M
+23.6%
Operating Cash Flow
$1.23M
+13.3%